TriangleNCT00625729 · OUTCOME
Number of Patients With Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 6 Months
What was measured
Number of patients alive at 6 months after treatment.
Groups in this outcome
Patients Treated With Natural Killer Cells
Patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with 1 dose donor natural killer cells infusion, 4 doses rituximab, 6 doses aldesleukin and 5 doses fludarabine and 1 dose cyclosphosphamide.
| Group | Source count |
|---|---|
| Patients Treated With Natural Killer Cells | 6 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Patients Treated With Natural Killer Cells | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- anticipated Posting Date
- 2010-06
- classes
- categories
- measurements
- group Id
- OG000
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 6
- units
- Participants
- description
- Number of patients alive at 6 months after treatment.
- groups
- description
- Patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with 1 dose donor natural killer cells infusion, 4 doses rituximab, 6 doses aldesleukin and 5 doses fludarabine and 1 dose cyclosphosphamide.
- id
- OG000
- title
- Patients Treated With Natural Killer Cells
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 6 Months
- title
- Number of Patients With Overall Survival
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice